Keyphrases
2-dose
14%
Beta-blockers
28%
Blood Pressure
100%
Ca2+
71%
Ca2+ Entry
14%
Canrenone
14%
Catalytic Subunit
14%
Elevated Blood Pressure
14%
Endogenous Ouabain
28%
High Dose
14%
Hypertension
14%
Induced Hypertension
14%
KB-R7943
14%
Low Blood Pressure
14%
Myocytes
28%
Myogenic Tone
100%
Na +
57%
Na+ Pump
42%
Ouabain
100%
Posterior Superior Temporal Sulcus (pSTS)
14%
Pressure Control
14%
Pressurized Arteries
14%
Reduced Expression
14%
Salt Retention
14%
Salt-sensitive Hypertension
28%
SEA0400
14%
Small Arteries
14%
Sodium Pump
100%
Vascular Resistance
14%
Wild Mice
14%
Medicine and Dentistry
2 [4 (2,5 Difluorobenzyloxy)phenoxy] 5 Ethoxyaniline
11%
Adenosine Triphosphatase (Potassium Sodium)
100%
Artery
55%
Blood Pressure
100%
Calcium Ion
66%
Canrenone
11%
Drug Megadose
11%
Elevated Blood Pressure
11%
Enzyme Active Site
11%
Hypotension
11%
In Vitro
11%
Low Drug Dose
11%
Muscle Cell
22%
Ouabain
100%
Sodium Ion
44%
Sodium Retention
11%
Table Salt
33%
Vascular Resistance
11%
Pharmacology, Toxicology and Pharmaceutical Science
2 [4 (2,5 Difluorobenzyloxy)phenoxy] 5 Ethoxyaniline
11%
Adenosine Triphosphatase (Potassium Sodium)
100%
Calcium Ion
66%
Canrenone
11%
Elevated Blood Pressure
11%
Hypotension
11%
Ouabain
100%
Sodium Ion
44%
Table Salt
44%
Wild Type Mouse
11%
Biochemistry, Genetics and Molecular Biology
Blood Pressure
100%
Drug Megadose
11%
Enzyme Active Site
11%
Low Drug Dose
11%
Ouabain
100%
Sodium Retention
11%
Vascular Resistance
11%
Wild Type Mouse
11%